The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.10 - Manufacture of basic pharmaceutical products
144 jobs Number of planned job losses
Announcement Date
19 June 2019
Employment effect (start)
19 June 2019
Foreseen end date
17 June 2020
Description
The French pharmaceutical manufacturer Sanofi confirmed that it will be cutting 144 jobs at its site in Frankfurt-Höchst as part of the restructuring programme ‘Horizon 2020’. However, the company denied reports claiming that the job reduction will mainly affect the company’s diabetes research division. According to management, the job reduction will affect the entire plant in Frankfurt-Höchst with a maximum of 38 jobs in the diabetes research division affected. The company intends to emphasise on other ongoing projects.
Currently, Sanofi has 8,000 employees in Frankfurt-Höchst.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
